Skip to main content
logo
Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.810
+0.150 (5.64%)
Sep 2, 2026, 5:29 PM CET

Elicera Therapeutics AB Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-17.98-17.41-16.11-16.4-19.44-13.12
Depreciation & Amortization
--0.010.010.010.01
Other Operating Activities
---00-
Change in Accounts Payable
-1.380.521.160.15-1.320.1
Change in Other Net Operating Assets
-7.56-4.67-8.531.3112.17-1.28
Operating Cash Flow
-25.75-21.55-23.46-14.92-8.57-14.29
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Sale (Purchase) of Intangibles
-0--0--
Investment in Securities
---0.48--0
Investing Cash Flow
-0-0.48--0

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
50.622.0327.56--62
Other Financing Activities
-6.39-2.03-7.08---6.88
Financing Cash Flow
44.212020.48--55.12

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
18.47-1.55-2.98-14.44-8.5740.83

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-19.27-14.87-17.94-9.26-1.32-9.37
Unlevered Free Cash Flow
-19.27-14.87-17.91-9.21-1.24-9.37

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.010.010.050.080.130
Cash Income Tax Paid
-----0-
Change in Working Capital
-7.77-4.14-7.361.4610.85-1.18